WHO ICTRP trial
Study of the pathogenesis of functional dyspepsia: Impairment of duodenal…
ChiCTR2200060317 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200060317 |
|---|---|
| Public title | Study of the pathogenesis of functional dyspepsia: Impairment of duodenal epithelial barrier function |
| Scientific title | The novel pathogenesis of functional dyspepsia: mast cells induce the impairment of duodenal epithelial barrier through the PAR-2 receptor, via a pathway of ERK1/2 |
| Primary sponsor | The Third People's Hospital of Chengdu |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | functional dyspepsia |
| Interventions | Group 1:3 pieces of duodenal bulb and 3 pieces of duodenal descending segment mucosa tissue were taken by gastroscope forceps;Group 2:3 pieces of duodenal bulb and 3 pieces of duodenal descending segment mucosal tissues from healthy… |
| Registration date | May 28, 2022 |
| Target size | Group 1:30;Group 2:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: